ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients
Trédan, O., Ménétrier-Caux, C., Ray-Coquard, I., Garin, G., Cropet, C., Verronèse, E., Bachelot, T., Rebattu, P., E. Heudel, P., Cassier, P., Chabaud, S., Croughs, T., Dupont, P., C. Cadore, A., ClapiJournal:
Annals of Oncology
DOI:
10.1093/annonc/mdx058
Date:
March, 2017
File:
PDF, 43 KB
2017
File converter
More search results
More benefits 
